相关实验视频

Updated: Jun 20, 2025

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

一种新型和选择性的光配体用于研究腺A_2B受体

Foteini Patera^1,2,3, Sarah J Mistry^2,4, Nicholas D Kindon^2,4

¹Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Pharmacology research & perspectives

|July 20, 2024

概括

研究人员开发了一种新的光配体,PSB603-BY630,对腺A2B受体 (A2BR) 具有高度选择性. 这个工具可以研究A_2BR.

科学领域:

药理学药理学是指药理学的学科.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

光配体对于研究活细胞中的G蛋白结合受体 (GPCRs) 是至关重要的.
氨酸A_2B受体 (A_2BR) 在调节瘤微环境中的免疫反应中起着关键作用.
开发选择性工具对于理解复杂生物系统中的A_2BR功能至关重要.

研究的目的:

描述一种新型光配体,PSB603-BY630,其选择性和在研究人类腺A_2B受体 (A_2BR) 中的实用性.
评估PSB603-BY630在免疫细胞,特别是巨细胞中监测A_2BR结合的潜力.
评估PSB603-BY630在不同腺受体亚型中的功能活性和选择性.

主要方法:

使用纳米化酶标记的A_2BRs在HEK293G细胞中表达的高亲和度结合试验.
与其他腺受体亚型 (A₁R,A_2AR,A₃R) 相比,选择性分析.
与已知的A_2BR配体进行竞争约束研究.
使用Glosensor测量周期性AMP反应的功能测试.
流细胞计分析人类巨细胞上内源性A_2BR标签.

主要成果:

PSB603-BY630证明了对纳米化酶标记的A_2BRs.具有高亲缘关系的结合 (18.3nM).
该连接体对A_2BR表现出异常的选择性,与其他腺受体亚型的绑定是可以忽略不计的,最多500nM.
竞争研究证实了预期的A_2BR药理学.
功能性研究表明,PSB603-BY630作为激素反应的负基调节器.
流细胞计证实了人类巨细胞内源性A_2BRs的选择性标记.

结论:

PSB603-BY630是人类腺A_2B受体的一种高度选择性的光配体.
这种连接体可以有效地监测细胞系统中的A_2BR结合和功能,包括人类巨细胞.
PSB603-BY630代表了一种有价值的新工具,用于研究A_2BRs在瘤微环境和免疫细胞调节中的作用.

关键词:

这就是PSB603的原因.腺A2B受体的受体是什么作为一个对抗者的对抗者.光联结体是一种光联结体.结合链体的结合方式巨细胞是什么?巨细胞是什么?

更多相关视频

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

相关概念视频

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...